SEC 13F Intelligence

Managers / Q2 2024 · view latest →

MSD Partners, L.P.

CIK 0001514334 · 550 MADISON AVENUE, 20TH FLOOR, NEW YORK, NY, 10022 · (212) 303-1650

Reported Value
$1.0B
Q2 2024
Positions
18
Filings on Record
39
2019–present window
Filed
Aug 14, 2024
original filing

Summary

Msd Partners, L.P. reported $1.0B in U.S.-listed holdings across 18 positions for Q2 2024.

The portfolio is heavily concentrated: HAYW alone accounts for 86.1% of reported value.

Compared with Q1 2024, the fund opened 1 new position and exited 1.

Portfolio Metrics

Turnover
+0.2%
vs prior filed quarter
Top-10 Concentration
+99.6%
share of reported value
Largest Position
+86.1%
Hayward
New / Exited
1 / 1
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $916MQ4 ’18Q1 ’19: $808MQ2 ’19: $825MQ3 ’19: $745MQ4 ’19: $454MQ4 ’19Q1 ’20: $370MQ2 ’20: $392MQ3 ’20: $478MQ4 ’20: $598MQ4 ’20Q1 ’21: $1.4BQ2 ’21: $2.0BQ3 ’21: $1.7BQ4 ’21: $1.1BQ4 ’21Q1 ’22: $645MQ2 ’22: $585MQ3 ’22: $597MQ4 ’22: $1.0BQ4 ’22Q1 ’23: $1.2BQ2 ’23: $1.1BQ3 ’23: $1.2BQ4 ’23: $1.2BQ4 ’23Q1 ’24: $1.2BQ2 ’24: $1.0BQ3 ’24: $158MQ4 ’24: $142MQ4 ’24Q1 ’25: $134MQ2 ’25: $172MQ3 ’25: $151MQ4 ’25: $109MQ4 ’25Q1 ’26: $82Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 90.8%Other: 8.5%REIT: 0.4%US DOMESTIC: 0.3%Equity WRT: 0.0%
  • Common Stock · 90.8% · $928M
  • Other · 8.5% · $86M
  • REIT · 0.4% · $4M
  • US DOMESTIC · 0.3% · $3M
  • Equity WRT · 0.0% · $217,333

Quarter-over-Quarter Changes full breakdown →

vs Q1 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
THERIVA BIOLOGICS INCNEW+598.4K598.4K+$141,405$141,405
HLTHQCUE HEALTH INCSOLD OUT−395.2K0−$74,544$0
HAYWHAYWARD HLDGS INCHELD+071.54M−$215M$880M
ODDITY TECH LTDHELD+01.78M−$6M$70M
XPOFXPONENTIAL FITNESS INCHELD+01.76M−$2M$27M
ASTLALGOMA STL GROUP INCHELD+0810.0K−$1M$6M
ALAUNOS THERAPEUTICS INCHELD+01.01M−$1M$706,061
ICDUSDINDEPENDENCE CONTRACT DRILLIHELD+01.70M−$952,560$2M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2024

18 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1HAYWHAYWARD HLDGS INChistory →COM86.09%$880M71.54M
2ODDITY TECH LTDSHS CL A6.84%$70M1.78M
3XPOFXPONENTIAL FITNESS INChistory →COM CL A2.69%$27M1.76M
4RENEW ENERGY GLOBAL PLCCL A SHS1.59%$16M2.61M
5ASTLALGOMA STL GROUP INCCOM0.55%$6M810.0K
6AESIATLAS ENERGY SOLUTIONS INCCOM NEW0.46%$5M237.7K
7LTHLIFE TIME GROUP HOLDINGS INCCOMMON STOCK0.42%$4M230.0K
8SAFESAFEHOLD INCCOM0.42%$4M222.6K
9DISH NETWORK CORPORATIONNOTE 3.375% 8/10.32%$3M5.00M
10ICDUSDINDEPENDENCE CONTRACT DRILLICOM0.22%$2M1.70M
11CCOCLEAR CHANNEL OUTDOOR HLDGSCOM0.17%$2M1.22M
12ALAUNOS THERAPEUTICS INCCOM NEW0.07%$706,0611.01M
13PGENPRECIGEN INCCOM0.05%$560,900355.0K
14IHRTIHEARTMEDIA INCCOM CL A0.05%$538,235493.8K
15TRISALUS LIFE SCIENCES INC*W EXP 08/10/2020.02%$217,333133.3K
16THERIVA BIOLOGICS INCCOM NEW0.01%$141,405598.4K
17DANIMER SCIENTIFIC INCCOM CL A0.01%$90,480150.0K
182CHWHEELS UP EXPERIENCE INCCOM CL A0.00%$37,80020.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$82M8May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$109M7Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$151M7Nov 13, 202513F-HRchanges · EDGAR ↗
Q2 2025$172M7Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$134M9May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$142M9Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$158M17Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$1.0B18Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$1.2B18May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023REVEALED$1.2B40Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$1.2B69Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$1.1B70Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$1.2B73May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$1.0B77Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$597M80Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$585M90Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$645M91May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$1.1B119Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$1.7B111Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$2.0B106Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.4B81May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$598M39Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$478M34Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$392M27Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$370M26May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$454M18Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$745M27Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$825M26Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$808M26May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$916M25Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.